Multicenter phase II trial of first-line docetaxel/gemcitabine in advanced breast cancer pretreated with adjuvant anthracyclines.
Vici P, Giotta F, DI Lauro L, Brandi M, Gebbia V, Foggi P, Lorusso V, Vitucci C, Sergi D, Fattoruso SI, Giannarelli D, Viola G, Corsetti S, Colucci G, Lopez M.
Vici P, et al. Among authors: di lauro l.
Anticancer Res. 2009 May;29(5):1841-5.
Anticancer Res. 2009.
PMID: 19443414
Free article.
Clinical Trial.